Clinical Trials Browser

Phase 2 × monalizumab × 90 days × Clear all

NCT05061550 2026-05-22

NeoCOAST-2

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07146230 2026-05-06

SPRINT 2

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05903092 2026-04-29

MOZART

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT06503614 2026-04-08

ENHANCE

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06152523 2026-04-06

MONAMI

Phase 2 Withdrawn

Neoplasms

NCT06769126 2026-03-30

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Phase 2 Recruiting

Small Cell Lung Carcinoma